ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 113,49
-1,01%
Dow Jones
39 806,77
0,00%
DAX
18 673,38
-0,50%
Brent Oil
82,075
-1,74%
Bitcoin
71 303,67
-0,22%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. X4 Pharmaceuticals Inc (XFOR)

  7. X4 Pharmaceuticals Inc (XFOR) Actualités

XFOR

X4 Pharmaceuticals (XFOR)

X4 Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:XFOR
DateHeureSourceTitreSymboleSociété
09/05/202412h58Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XFORX4 Pharmaceuticals Inc
11/03/202422h20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XFORX4 Pharmaceuticals Inc
11/03/202421h16Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:XFORX4 Pharmaceuticals Inc
28/02/202423h52Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:XFORX4 Pharmaceuticals Inc
14/02/202422h44Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:XFORX4 Pharmaceuticals Inc
14/02/202422h32Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:XFORX4 Pharmaceuticals Inc
25/01/202422h23Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:XFORX4 Pharmaceuticals Inc
09/11/202323h11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:XFORX4 Pharmaceuticals Inc
18/10/202322h00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:XFORX4 Pharmaceuticals Inc
25/08/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:XFORX4 Pharmaceuticals Inc
26/06/202322h16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XFORX4 Pharmaceuticals Inc
23/06/202321h27Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:XFORX4 Pharmaceuticals Inc
21/06/202312h06Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:XFORX4 Pharmaceuticals Inc
21/06/202312h03Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:XFORX4 Pharmaceuticals Inc
16/06/202322h05Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:XFORX4 Pharmaceuticals Inc
09/06/202322h13Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:XFORX4 Pharmaceuticals Inc
01/06/202322h40Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:XFORX4 Pharmaceuticals Inc
01/06/202322h17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:XFORX4 Pharmaceuticals Inc
26/05/202321h05Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:XFORX4 Pharmaceuticals Inc
04/05/202322h24Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:XFORX4 Pharmaceuticals Inc
27/04/202322h27Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:XFORX4 Pharmaceuticals Inc
25/04/202322h11Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:XFORX4 Pharmaceuticals Inc
21/03/202321h25Edgar (US Regulatory)Annual Report (10-k)NASDAQ:XFORX4 Pharmaceuticals Inc
14/02/202323h41Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:XFORX4 Pharmaceuticals Inc
12/12/202220h35TipRanksX4 Pharmaceuticals (XFOR) Receives a New Rating from Brookline Capital MarketsNASDAQ:XFORX4 Pharmaceuticals Inc
09/12/202212h04Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:XFORX4 Pharmaceuticals Inc
07/12/202213h12TipRanksX4 Pharma Tanks on Public OfferingNASDAQ:XFORX4 Pharmaceuticals Inc
30/11/202213h35TipRanksB.Riley Financial Keeps Their Buy Rating on X4 Pharmaceuticals (XFOR)NASDAQ:XFORX4 Pharmaceuticals Inc
30/11/202201h05TipRanksBrookline Capital Markets Sticks to Its Buy Rating for X4 Pharmaceuticals (XFOR)NASDAQ:XFORX4 Pharmaceuticals Inc
08/11/202203h07TipRanksX4 Pharmaceuticals (XFOR) Receives a Buy from Stifel NicolausNASDAQ:XFORX4 Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:XFOR

Dernières Valeurs Consultées

NYSE
DIS
Walt Disney
EU
AI
Air Liquide
NYSE
NKE
Nike
EU
BN
Danone
EU
PX1
CAC 40
EU
LR
Legrand
COIN
BTCUSD
Bitcoin
NASDAQ
MSFT
Microsoft
EU
CS
Axa
EU
CAP
Capgemini
NASDAQ
GOOGL
Alphabet
NASDAQ
AMZN
Amazon.com
EU
BNP
BNP Paribas
EU
ACA
Credit Agricole
EU
EN
Bouygues
NYSE
MRK
Merck
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés